Suppr超能文献

用于造血祖细胞采集和移植的多用途硅橡胶双腔中心静脉导管。

Multi-purpose silastic dual-lumen central venous catheters for both collection and transplantation of hematopoietic progenitor cells.

作者信息

Lazarus H M, Trehan S, Miller R, Fox R M, Creger R J, Raaf J H

机构信息

Department of Medicine, University Hospitals of Cleveland, Cleveland, OH 44106, USA.

出版信息

Bone Marrow Transplant. 2000 Apr;25(7):779-85. doi: 10.1038/sj.bmt.1702225.

Abstract

Autologous peripheral blood progenitor cell (PBPC) transplantation frequently requires sequential placement and use of two separate central venous catheters: (1) a short-term, large-bore, stiff device inserted for leukapheresis, and after removal of that device, (2) a long-term, multi-lumen, flexible, Silastic catheter for administration of high-dose chemotherapy, re-infusion of hematopoietic cells, and intensive supportive care. We reviewed our recent experience with two dual-lumen, large-bore, Silastic multi-purpose ('hybrid') catheters, each of which can be used as a single device for both leukapheresis and long-term supportive care throughout the transplant process. Quinton-Raaf PermCath and Bard-Hickman hemodialysis/apheresis dual-lumen catheters were used as the sole venous access device in 112 consecutive patients who underwent autologous PBPC collection and transplantation. The catheter exit site was monitored three times a week, and lumen patency was assessed using clinical and radiologic techniques. Catheters were removed prematurely for persistent thrombus, positive blood cultures despite appropriate antibiotics, or mechanical dysfunction. There were no intra-operative or immediate post-operative complications relating to insertion. Thirty-two patients experienced catheter occlusion necessitating urokinase instillation. Persistent occlusive problems were noted in 16 patients, and in 10 patients the catheter had to be removed. Two exit site infections and 17 bacteremias occurred. Catheters had to be removed for persistent infection in two subjects and for mechanical problems in five others. Cost analysis comparing the hybrid catheters alone vs conventional devices revealed a charge of $4230 in patients with hybrid catheters vs. $7530 in those requiring a temporary non-Silastic dialysis catheter in addition to a flexible, long-term Silastic catheter. Hybrid, Silastic, dual-lumen, large-bore central venous catheters are safe, cost-effective and convenient multi-purpose venous access devices that may be used in the setting of autologous PBPC collection and transplantation. The rate of thrombotic, infectious and mechanical complications appears comparable to other central venous access devices.

摘要

自体外周血祖细胞(PBPC)移植通常需要先后放置并使用两根不同的中心静脉导管:(1)一根短期、大口径、硬管装置,用于白细胞分离术,该装置移除后,(2)一根长期、多腔、柔软的硅橡胶导管,用于给予高剂量化疗、回输造血细胞以及强化支持治疗。我们回顾了近期使用两根双腔、大口径、硅橡胶多功能(“混合型”)导管的经验,每根导管都可在整个移植过程中作为单一装置用于白细胞分离术和长期支持治疗。昆顿 - 拉夫PermCath导管和巴德 - 希克曼血液透析/血液分离双腔导管被用作112例连续接受自体PBPC采集和移植患者的唯一静脉通路装置。每周对导管出口部位监测三次,并使用临床和放射学技术评估管腔通畅情况。导管因持续性血栓形成、尽管使用了适当抗生素仍出现血培养阳性或机械功能障碍而提前拔除。未发生与插入操作相关的术中或术后即刻并发症。32例患者出现导管堵塞,需要滴注尿激酶。16例患者存在持续性堵塞问题,10例患者的导管不得不拔除。发生了2例出口部位感染和17例菌血症。2例患者因持续性感染、5例患者因机械问题而不得不拔除导管。对单独使用混合型导管与传统装置进行成本分析发现,使用混合型导管的患者费用为4230美元,而除了一根柔软的长期硅橡胶导管外还需要一根临时非硅橡胶透析导管的患者费用为7530美元。混合型、硅橡胶、双腔、大口径中心静脉导管是安全、经济高效且方便的多功能静脉通路装置,可用于自体PBPC采集和移植。血栓形成、感染和机械并发症的发生率似乎与其他中心静脉通路装置相当。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验